Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Blasts More Than 5 Percent of Peripheral Blood White Cells

Tundra lists 1 Blasts More Than 5 Percent of Peripheral Blood White Cells clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT03801434

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.

Gender: All

Ages: 18 Years - Any

Updated: 2025-12-23

4 states

BCR-JAK2 Fusion Protein Expression

Blasts 20 Percent or Less of Peripheral Blood White Cells

Blasts More Than 5 Percent of Bone Marrow Nucleated Cells